p>The risk of herpes zoster, commonly known as shingles, was not increased in vaccinated children, and appeared to be lower in vaccinated children than in the pre-vaccine era. There were 46 confirmed cases of shingles among the cohort, suggesting an approximately 40 percent decreased incidence of herpes zoster in vaccinated children.
Additional authors on the study include Paula Ray , MPH, Edwin Lewis , MPH, and Bruce Fireman, MA, with the Kaiser Permanente Vaccine Study Center; Patricia Saddier , MD, PhD, and Trung N. Tran , MD, PhD, of the epidemiology department, Merck Sharp & Dohme, Corp., Whitehouse Station, N.J.; Steve Black , MD, of the Center for Global Health, Cincinnati Children's Hospital, Cincinnati; Henry R. Shinefield , MD, of the University of California San Francisco Medical Center; and Paul M. Coplan ScD, MBA, of Purdue Pharma, Stamford, Conn.
Trung Nam Tran , MD, and Paul Coplan were employees of Merck Sharp & Dohme, Corp. at the time of the study. Patricia Saddier, MD, is currently still an employee of Merck Sharp & Dohme, Corp. Roger Baxter , MD, has received research grants from Merck, Sanofi Pasteur, GSK and Novartis. Steve Black , MD, is a consultant for Novartis, and is on data safety monitoring boards for Novartis, GSK and the World Health Organization. All other authors report no conflicts of interest.
About the Kaiser Permanente Vaccine Study CenterPage: 1 2 3 4 5 Related medicine technology :1
Founded in 1985, the Kaiser Permanente Vaccine Study Center began as a way of responding to numerous requests to use Kaiser Permanente's large population for vaccine efficacy stu
. Army Researcher Develops Potential Vaccine Carrier That May Give Stockpiling Efforts A Shot In The Arm2
. Shingles Vaccine is Safe, According to New Study3
. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability4
. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer5
. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine6
. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine7
. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 20128
. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial9
. Global Human Vaccines Industry10
. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine11
. HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs Second Generation HIV Vaccine